GetTopicDetailResponse(id=ffec11e19206, topicName=化療放療, introduction=, content=NSCLC 阿替利珠單抗 化療放療, image=null, comments=0, allHits=787, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sun Jul 28 17:40:46 CST 2024, time=2024-07-28, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=493686, tagList=[TagDto(tagId=493686, tagName=化療放療)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2217251, encodeId=58ad221e25178, content=<a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a> <a href='/topic/show?id=6bf49e844e9' target=_blank style='color:#2F92EE;'>#阿替利珠單抗#</a> <a href='/topic/show?id=ffec11e19206' target=_blank style='color:#2F92EE;'>#化療放療#</a>, objectTitle=JAMA Oncol | 新輔助阿替利珠單抗聯(lián)合化療放療治療不可切除性 III 期 NSCLC 的療效和安全性, objectType=article, longId=836546, objectId=708883654699, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720663740076_92910.png, objectUrl=/article/show_article.do?id=708883654699, replyNumber=0, likeNumber=145, createdTime=2024-07-28, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=708883654699, moduleTitle=JAMA Oncol | 新輔助阿替利珠單抗聯(lián)合化療放療治療不可切除性 III 期 NSCLC 的療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=708883654699)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-07-28發(fā)表于上海
